Healthcare Triangle to Issue Over $37M in Stock & Preferred Shares, Facing Extreme Dilution
HCTI is trading near its 52-week low of $1.88 (8.5% above the low) on light trading volume (0.1× avg).
Summary
Healthcare Triangle is set to issue over $37 million in common and convertible preferred stock for a "make-whole" settlement and an acquisition, representing extreme potential dilution of more than 900% of its current market cap.
Key Events · Financing and Capital Events · HCTI
-
Massive Dilution for SecureKloud Settlement
Healthcare Triangle will issue 2,828,167 common shares, valued at approximately $5.8 million, to SecureKloud Technologies as a 'make-whole' settlement. This compensates SecureKloud for the devaluation of previously issued preferred stock due to reverse stock splits.
-
Significant Equity for Teyame AI Acquisition
An amendment to a share purchase agreement for the Teyame AI acquisition includes $12 million in restricted common stock and 18,000 shares of Series C Convertible Preferred Stock, potentially convertible into an additional 7,743,780 common shares (worth ~$15.8 million).
-
Management Earnout in Preferred Stock
An additional 5,000 shares of Series C Convertible Preferred Stock, potentially convertible into 2,151,050 common shares (worth ~$4.4 million), are designated for key management employees as a post-closing earnout.
-
New Series C Preferred Stock Authorized
The company filed a Certificate of Designations for 23,000 shares of Series C Convertible Preferred Stock, with a stated value of $1,000 per share, convertible into 430.2 common shares each, subject to shareholder approval.
Analysis · HCTI · Technology
Healthcare Triangle has entered into agreements that will result in substantial dilution for existing shareholders. The company is issuing approximately $5.8 million in common stock as a "make-whole" to SecureKloud Technologies due to past reverse stock splits that devalued previous preferred stock. Additionally, an amendment to a share purchase agreement for the Teyame AI acquisition involves issuing $12 million in restricted common stock and preferred stock convertible into an additional $20 million worth of common shares. These issuances, totaling over $37 million in potential value, represent more than nine times the company's current market capitalization and require shareholder approval, indicating a significant restructuring of the company's equity base.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 43.2% of the 271 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.30%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HCTI was trading at $2.04 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $1.88 to $1,299.77. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.